Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierStanford University
dc.contributor.authorPALESH, Oxana
hal.structure.identifierStanford University
dc.contributor.authorALDRIDGE-GERRY, Arianna
hal.structure.identifierHôpital Paul Brousse
dc.contributor.authorULUSAKARYA, Ayhan
hal.structure.identifierInstitut National de la Santé et de la Recherche Médicale [INSERM]
dc.contributor.authorORTIZ-TUDELA, Elisabet
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorCAPURON, Lucile
IDREF: 167018736
hal.structure.identifierHôpital Paul Brousse
dc.contributor.authorINNOMINATO, Pasquale F
dc.date.accessioned2022-03-16T14:54:07Z
dc.date.available2022-03-16T14:54:07Z
dc.date.issued2013-12-01
dc.identifier.issn1540-1413en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/136491
dc.description.abstractEnSleep disruption is prevalent in patients and survivors of breast cancer. Most patients undergoing chemotherapy will experience transient sleep disruption, and nearly 60% will have chronic sleep problems. Numerous factors contribute to sleep disruption in women diagnosed with breast cancer. Sleep disruption is a consequence of several biological alterations, including circadian disruption and immune and metabolic deregulations. These systems also play significant roles in the control and progression of breast cancer. Sleep disruption is associated with many side effects and psychiatric and medical comorbidities. This article discusses the relationship between stress and posttraumatic stress disorder, depression and fatigue, and how sleep disturbance might be the cause or consequence of these disorders. Current evidence for management of sleep disturbance in breast cancer and high chronic use of hypnotic medication in this population is also discussed. Finally, the differences in management of sleep disturbance during acute cancer care and during the survivorship phase are discussed. More research is needed on accurate and timely assessment of sleep disturbance associated with breast cancer, and additional tailored approaches for the management of sleep problems in breast cancer should be developed.
dc.language.isoENen_US
dc.subject.enBreast Neoplasms
dc.subject.enCircadian Clocks
dc.subject.enFemale
dc.subject.enHumans
dc.subject.enPractice Guidelines as Topic
dc.subject.enRisk Factors
dc.subject.enSleep Wake Disorders
dc.subject.enSurvivors
dc.title.enSleep disruption in breast cancer patients and survivors.
dc.title.alternativeJ Natl Compr Canc Netwen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.6004/jnccn.2013.0179en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed24335687en_US
bordeaux.journalJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKen_US
bordeaux.page1523-30en_US
bordeaux.volume11en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.issue12en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=JOURNAL%20OF%20THE%20NATIONAL%20COMPREHENSIVE%20CANCER%20NETWORK&rft.date=2013-12-01&rft.volume=11&rft.issue=12&rft.spage=1523-30&rft.epage=1523-30&rft.eissn=1540-1413&rft.issn=1540-1413&rft.au=PALESH,%20Oxana&ALDRIDGE-GERRY,%20Arianna&ULUSAKARYA,%20Ayhan&ORTIZ-TUDELA,%20Elisabet&CAPURON,%20Lucile&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée